Drug Reimportation Schemes Will Turn Out to Be Clunkers

In the automobile business, what’s known as a “lemon” can’t truly be fixed. A new set of tires or a fresh coat of paint won’t make a difference if the machinery under the hood is poorly designed. The government policy world has its share of “lemons” too, and few have been as enduringly disappointing as the idea of importing prescription drugs from other countries with the hope to bring cheaper medications to patients and taxpayers.

Read the full story here.